Century Therapeutics Inc (IPSC) — Financial Flexibility Index
Century Therapeutics Inc (IPSC) has a Financial Flexibility Index of -0.24x as of December 2025. Free cash flow of $-15.76 Million (operating CF $-16.08 Million minus capex $317.00K) represents 0% of total liabilities ($64.77 Million). Also explore IPSC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Century Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Century Therapeutics Inc across 8 annual periods. Check IPSC strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Century Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Century Therapeutics Inc. For the full company profile including market capitalisation, see IPSC stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.59x | $-103.03 Million | $-103.88 Million | $64.77 Million | ▼ -177.5% |
| 2024 | -0.57x | $-109.98 Million | $-110.14 Million | $191.85 Million | ▼ -35.2% |
| 2023 | -0.42x | $-74.61 Million | $-88.35 Million | $175.94 Million | ▼ -274.6% |
| 2022 | 0.24x | $44.66 Million | $14.05 Million | $183.81 Million | ▲ +122.7% |
| 2021 | -1.07x | $-44.03 Million | $-89.00 Million | $41.14 Million | ▼ -625.7% |
| 2020 | -0.15x | $-31.44 Million | $-41.27 Million | $213.19 Million | ▼ -96.6% |
| 2019 | -0.08x | $-13.71 Million | $-16.17 Million | $182.75 Million | ▼ -127.2% |
| 2015 | 0.28x | $133.69 Million | $104.30 Million | $484.99 Million | — |